Astri Fjelde Maaland

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Fluorescent Probe

Energy Transfer

Top Venues

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Marion M Malenge, Astri Fjelde Maaland, Ada H V Repetto-Llamazares, Brian Middleton, Marcel Nijland, Lydia Visser, Sebastian Patzke, Helen Heyerdahl, Arne Kolstad, Trond Stokke, Anne Hansen Ree, Jostein Dahle
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro. PloS one 17 (4) (2022)
Astri Fjelde Maaland, Amal Saidi, Julien Torgue, Helen Heyerdahl, Tania A Rozgaja Stallons, Arne Kolstad, Jostein Dahle
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003. PloS one 15 (3) (2020)
Astri Fjelde Maaland, Helen Heyerdahl, Adam O'Shea, Bergthora Eiriksdottir, Véronique Pascal, Jan Terje Andersen, Arne Kolstad, Jostein Dahle
Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003. European journal of nuclear medicine and molecular imaging 46 (11) (2019)